A Decrease in the Number of Children Being Born has Impacted Sales in the Contraceptives Market in the United States.
With an increasing number of generic oral contraceptives on the market, sales of condoms and oral contraceptives declined 6.1% between 2000 and 2005 (after inflation). These generic oral contraceptives can sell for as much as 80% less than brand name products.
Consumer data show that while 15% of adults use condoms, this number could increase, considering that the U.S. has the highest rate of STDs of all industrial countries. The U.S. government and many not-for-profit organizations are spending millions of dollars to promote safe sexual health and the use of condoms. Should a condom manufacturer choose to dovetail an educational marketing campaign with the government and private sector promotions to increase awareness, directed at all sectors, sales increases could be the result.
New product development is the primary market strategy of pharmaceutical companies, in particular, development of products with added health benefits like acne prevention and pre-menopausal relief. Condom manufacturers also have new products and are developing marketing campaigns to catch the attention of younger and higher risk consumers.
Several other factors are impacting sales in the market, including a declining female population of prime childbearing years. However, some of those challenges are offset by other factors, such as the reduced number of children being born and the increased number of women delaying childbirth or deciding against having children altogether. For condom manufacturers, two hurdles are increasing awareness of STD prevention among consumers and successfully promoting an increased-sensitivity condom.
This report clearly identifies the principal external factors driving or curtailing growth. Exclusive consumer research reveals the attitudes, needs and behavior of consumers, with analysis broken down both by demographic characteristics, and by segment.
Six years of specific sales data provide a factual and impartial presentation of the market as a whole. The report also evaluates the performance of individual sectors in the market, and provides information about the major companies and brands. Using the SPSS forecasting package, a five-year forecast of U.S. retail sales is created, revealing potential opportunities for growth and product development.
The contraceptive market is defined as including all products used for birth control or as prophylactics in sexual relationships. Included are non-permanent forms of contraception: oral contraceptives, chemical, barrier and hormone-releasing implant methods, whether available over-the-counter or on prescription. This includes male and female condoms, spermicides, diaphragms/caps, oral contraceptives (birth control pills), intra-uterine devices, and injections. Natural methods of birth control or permanent contraceptives such as tubaligation and vasectomy procedures are referred to in order to indicate trends within the market, but are not included in the market size.
--Johnson & Johnson
--Church & Dwight
For more information visit http://www.researchandmarkets.com/reports/c40266
|Printer friendly Cite/link Email Feedback|
|Date:||Aug 3, 2006|
|Previous Article:||Over A Five Year Period the Cat Care Market Grew at an Annual Rate of 3.3% in the USA.|
|Next Article:||Research and Markets: Pfizer Inc was the Leading Company Operating in the Pet Health Care Market in the USA.|